280 likes | 618 Views
Slow viral or prion diseases of the central nervous system. Professor Sudheer Kher. Slow viral diseases of the central nervous system. tempo of clinical disease protracted incubation period (may also be protracted course of disease) multiple neurological symptoms.
E N D
Slow viral or prion diseases of the central nervous system Professor SudheerKher
Slow viral diseases of the central nervous system • tempo of clinical disease • protracted incubation period • (may also be protracted course of disease) • multiple neurological symptoms
Diseases caused by slow viruses • Creutzfeld-Jakob disease (CJD) • GSS- Gerstmann-Straussler-Scheinker syndrome • FFI- Fatal familial Insomnia • SSPE- SubacteSclerosing Pan Encephalitis • PML – Progressive Multifocal Leucoencephalopathy
Kuru Fore tribe of New Guinea Predominant in women & children Progressive cerebellar ataxia and tremors Tribal practice of eating dead bodies of relatives after a “nonsterilising” ritual cooking No specific diagnosis or treatment
SLOW INFECTIONS IN HUMANS • VIRUSES • SV40-like viruses (PML) • measles virus (SSPE) • rubella virus (PRP) PROGRESSIVE RUBELLA PANENCEPHALITIS • ATYPICAL AGENTS • Kuru, • Creutzfeld-Jakob disease (CJD) • (new) variant CJD disease (vCJD=nvCJD)
Progressive multifocal leukoencephalopathy • Polyoma virus family, SV40-like (JC virus etc) • progressive, usually fatal, associated with immune suppression • HAART may prolong life in AIDS patients • but little effect on PML incidence • typically non inflammatory • but can get an inflammatory response in the brain after HAART treatment (immune reconstitution inflammatory syndrome) • demyelination (oligodendrocytes infected)
SYMPTOMS • weakness • speech problems • cognitive problems • headaches • gait problems • visual problems • sensory loss • seizures http://library.med.utah.edu/WebPath/TUTORIAL/AIDS/AIDS076.html
Progressive multifocal leukoencephalopathy • reactivation of latent infection • 70-80% population are seropositive • associated with immunosuppression • 1979: 1.5 per 10,000,000 population • 2004: 1 in 20 AIDS patients
BK virus (polyoma) • Associated with urinary tract infections in immunosuppression • Possibly contributory factor in prostate cancer???
MEASLES VIRUS • paramyxovirus family (morbillivirus genus) • sub-acute sclerosing panencephalitis • inflammatory disease • defective virus • ~1-10 yrs after initial infection • early infection with measles is a risk factor • rare complication of measles (7-70 cases per 1,000,000 cases measles) • vaccine protects against SSPE
RUBELLA VIRUS • togavirus family (rubrivirus genus) • progressive rubella panencephalitis • inflammatory disease • years after initial infection • congenital / very early infections • very very rare
Transmissible subacute spongiform encephalopathies Transmissible cerebral amyloidoses Prion diseases
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSEs, TRANSMISSIBLE CEREBRAL AMYLOIDOSES, PRION DISEASES) • human • Kuru • Creutzfeldt-Jakob disease (CJD) • Gerstmann-Straussler-Scheinker syndrome (GSS) • fatal familial insomnia (FFI) • variant CJD (‘human BSE’) • animal • scrapie (sheep and goats) • bovine spongiform encephalopathy (BSE) Mad Cow Disease • transmissible mink encephalopathy • etc
ATYPICAL AGENTS • atypical viruses • atypical agents • prions
ATYPICAL AGENTS • SIMILAR TO VIRUSES • small • filterable • need host cells • no machinery for energy generation or protein synthesis • DIFFERENT FROM VIRUSES • no detectable virions in infected tissues • no detectable virions in purified infectious material • if nucleic acid is present, very small • very resistant to inactivation
RESISTANT TO OR ONLY PARTIALLY INACTIVATED BY: • formaldehyde • ethanol • glutaraldehyde • ultraviolet and ionizing irradiation • non-ionic detergents • INACTIVATED BY: • autoclaving (121C for one hour) (> standard) • 5% sodium hypochlorite • sodium hydroxide • proteases, urea, other protein denaturants
purified infectious material • protein present (PrP) • proteases inactivate • nucleic acid controversial • but little or none PRION
PRION DISEASE • CNS • LONG INCUBATION • SLOW COURSE OF DISEASE (FATAL) • SPONGIFORM ENCEPHALOPATHY • VACUOLATION OF NEURONS • FIBRILLAR AGGREGATES, AMYLOID-TYPE MATERIAL (form plaques) • RARE IN MAN http://www.cdc.gov/ncidod/dvrd/cjd/ (Ermias Belay)
Helical - Happy Beta-pleated sheet - Bad PRION PROTEIN (PrP)(host cell gene) PrP or PrPC alpha-helical protease sensitive PrPRES or PrPSC beta-pleated sheet protease resistant
SCRAPIE • sheep • loss of muscular control • wasting • glial proliferation • vacuolation of neurons • amyloid plaques • abnormal properties infectious material • does not seem to cross sheep/human species barrier
KURU • human disease • tremors, ataxia, weakness • dementia, death • amyloid plaques • spongiform changes • transmission – contact with infectious material
CREUTZFELDT-JAKOB DISEASE • spongiform appearance of brain at autopsy • dementia, myoclonus, ataxia • 16-80+, usually 50-70 • Median age at death in US=68 yrs • 10% familial • also sporadic form • also acquired form (eg. iatrogenic CJD) • several hundred deaths in US per year
CREUTZFELDT-JAKOB DISEASEclassical form • no evidence for direct person to person transmission • blood • milk • other body fluids • intimate social contact
CREUTZFELDT-JAKOB DISEASE • iatrogenic CJD • human cadaver growth hormone • human cadaver gonadotropin • dural mater grafts • corneal transplantation • neurosurgical instruments • stereotactic EEG electrodes
variant CJD (vCJD) • patients younger at presentation, more protracted course of disease • median age at death for UK vCJD patients=28 yrs • often patients present with psychiatric symptoms • BSE connection • seems bovine/human barrier is easier to cross than sheep/human barrier • distinctive pathological appearance • distinctive properties of the PrPres • agent is in some peripheral tissues • lymphoid tissues • 2 probable cases where transmitted by blood • future? • two cases in US – both had spent time in UK
OTHER HUMAN PRION DISEASES • Gerstmann-Sträussler-Scheinker syndrome (GSS) (familial) • motor • sometimes regarded as subclass of CJD • fatal familial insomnia (FFI) • circadian rhythm problems • hypothalamus
IMMUNE RESPONSE • no inflammatory response • no interferon induction • no antibody response • no cell-mediated response
TREATMENT • invariably fatal • attempts at drug therapy disappointing • blood brain barrier